EUVIMEDEUVIMED entdecken
Crossref

Therapeutic potential of Periplaneta americana extract in neonatal necrotizing enterocolitis: role of NLRP3

Lin Li, Haosen Wang, Meng Zhou, Hui Ding, Yongfang Zhao, Ming Wu

Translational Pediatrics · 2026-11 · 15 (11) · 460-460

DOI: 10.21037/tp-2026-0711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Pediatrics, 2026-11. Verfasst von Lin Li und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal necrotizing enterocolitis (NEC) is a critical and devastating gastrointestinal disease in newborns that currently lacks effective pharmacological treatments. Kangfuxin (KFX) liquid, derived solely from Periplaneta americana (PA) extract, possesses well-documented anti-inflammatory and wound-healing properties across various clinical settings. However, its specific efficacy in mitigating intestinal inflammation and preserving intestinal barrier function in NEC remains unexplored. This study aims to investigate the efficacy of KFX and its underlying mechanisms in mitigating intestinal inflammation and preserving intestinal barrier function in NEC.

Methods

This study investigated the protective effects of KFX against NEC using clinical samples, in vivo models, and in vitro assays. Clinically, ileal segments from infants with NEC or intestinal atresia (IA) were collected for histology and immunohistochemistry (IHC). In vivo, NEC was induced in neonatal C57BL/6 mouse pups via hyperosmolar formula feeding and hypoxia stimulation, followed by treatment with varying doses of KFX. In vitro, human intestinal epithelial Caco-2 cells were subjected to lipopolysaccharide (LPS) stimulation in the presence or absence of KFX to elucidate the underlying molecular mechanisms.

Results

Analyses of both clinical samples and experimental models revealed a strong association between NEC pathogenesis and the activation of the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. In vivo, KFX administration significantly attenuated histopathological intestinal injury, reduced systemic inflammation and oxidative stress (OS), preserved intestinal barrier function, and exhibited excellent blood compatibility. Furthermore, KFX modulated macrophage polarization by suppressing the pro-inflammatory M1 phenotype and promoting the reparative, anti-inflammatory M2 phenotype. Mechanistically, KFX prevented the upstream assembly and activation of the NLRP3 inflammasome by disrupting the nuclear translocation of p65.

Conclusions

KFX exerts significant protective effects against NEC by reducing intestinal inflammation and maintaining mucosal barrier integrity. These therapeutic benefits are primarily mediated through the inhibition of p65 nuclear translocation and subsequent suppression of NLRP3 inflammasome activation. Therefore, KFX may offer a novel idea for the prevention of NEC.

Zitieren

APA

Li, L., Wang, H., Zhou, M., Ding, H., Zhao, Y., & Wu, M. (2026). Therapeutic potential of Periplaneta americana extract in neonatal necrotizing enterocolitis: role of NLRP3. Translational Pediatrics, 15(11), 460-460. https://doi.org/10.21037/tp-2026-0711

Vancouver

Li L, Wang H, Zhou M, Ding H, Zhao Y, Wu M. Therapeutic potential of Periplaneta americana extract in neonatal necrotizing enterocolitis: role of NLRP3. Translational Pediatrics. 2026;15(11):460-460. doi:10.21037/tp-2026-0711

BibTeX
@article{Li2026,
  author = {Li, Lin and Wang, Haosen and Zhou, Meng and Ding, Hui and Zhao, Yongfang and Wu, Ming},
  title = {Therapeutic potential of Periplaneta americana extract in neonatal necrotizing enterocolitis: role of NLRP3},
  journal = {Translational Pediatrics},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {460--460},
  doi = {10.21037/tp-2026-0711}
}
Kostenlos starten →